Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 287
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01918735 | A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects | ||
| NCT02660255 | Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy | ||
| NCT02038699 | A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer | ||
| NCT00371137 | A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia | ||
| NCT00710554 | A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia | ||
| NCT03485729 | ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer | ||
| NCT00901732 | Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer | ||
| NCT02954887 | Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7) | ||
| NCT02851407 | Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients | ||
| NCT02348632 | "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA" | ||
| NCT03929666 | A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer | ||
| NCT01401140 | Comparing the Protective Effects of Two Cardioplegic Solutions, on Cardiac Metabolism, as Assessed Using Microdialysis | ||
| NCT04425655 | Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia. | ||
| NCT01606176 | A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin | ||
| NCT00713817 | A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain | ||
| NCT04592159 | Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder | ||
| NCT00003966 | Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation | ||
| NCT05542407 | ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer | ||
| NCT04526288 | CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease | ||
| NCT01606202 | A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury | ||
| NCT05720494 | A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Healthy Participants | ||
| NCT00628498 | Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study | ||
| NCT07278505 | Study of Cannabidiol and Neuroimaging on Stress | ||
| NCT00457951 | A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD | ||
| NCT06961266 | A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1 | ||
| NCT04285788 | Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Transplant Recipients | ||
| NCT04323254 | Language of Sleepiness | ||
| NCT07102381 | A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer | ||
| NCT01143181 | Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses | ||
| NCT07156435 | Vyxeos® With Clofarabine for Pediatric AML | ||
| NCT01426295 | Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital | ||
| NCT03393611 | CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome | ||
| NCT03335267 | Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia | ||
| NCT05826756 | Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting | ||
| NCT05631327 | A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors | ||
| NCT04224272 | A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer | ||
| NCT00423605 | Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. | ||
| NCT02091375 | Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) | ||
| NCT03295396 | ONC201 in Adults With Recurrent H3 K27M-mutant Glioma | ||
| NCT03825796 | CPX-351 Plus Enasidenib for Relapsed AML | ||
| NCT04038437 | A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AML | ||
| NCT04732065 | ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors | ||
| NCT00506974 | Enhancing Slow Wave Sleep With Sodium Oxybate | ||
| NCT00711880 | A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia. | ||
| NCT05288283 | Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures | ||
| NCT02718755 | Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies | ||
| NCT00097708 | Experimental Medication For the Treatment of Generalized Anxiety Disorder | ||
| NCT07153055 | Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer | ||
| NCT01610687 | A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis | ||
| NCT01898520 | A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years |
